Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

What's the Best Way to Treat Normal-Weight People With Metabolic Abnormalities?

Rubin R.

JAMA. 2018 Jul 17;320(3):223-225. doi: 10.1001/jama.2018.8188. No abstract available.

PMID:
29955807
2.
3.

What is the evidence for a role for diet and nutrition in osteoarthritis?

Thomas S, Browne H, Mobasheri A, Rayman MP.

Rheumatology (Oxford). 2018 May 1;57(suppl_4):iv61-iv74. doi: 10.1093/rheumatology/key011. Review.

4.

Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes.

Shankar SS, Shankar RR, Mixson LA, Miller DL, Pramanik B, O'Dowd AK, Williams DM, Frederick CB, Beals CR, Stoch SA, Steinberg HO, Kelley DE.

Diabetes. 2018 Jun;67(6):1105-1112. doi: 10.2337/db17-1331. Epub 2018 Mar 15.

PMID:
29545266
5.

Internet-based programmes on weight loss appear to be effective for low-income postpartum women.

Gilmore LA, Redman LM.

Evid Based Nurs. 2018 Apr;21(2):42. doi: 10.1136/eb-2017-102804. Epub 2018 Mar 10. No abstract available.

PMID:
29525766
6.

EVIDENT 3 Study: A randomized, controlled clinical trial to reduce inactivity and caloric intake in sedentary and overweight or obese people using a smartphone application: Study protocol.

Recio-Rodriguez JI, Gómez-Marcos MA, Agudo-Conde C, Ramirez I, Gonzalez-Viejo N, Gomez-Arranz A, Salcedo-Aguilar F, Rodriguez-Sanchez E, Alonso-Domínguez R, Sánchez-Aguadero N, Gonzalez-Sanchez J, Garcia-Ortiz L; EVIDENT 3 investigators.

Medicine (Baltimore). 2018 Jan;97(2):e9633. doi: 10.1097/MD.0000000000009633.

7.

Case 31-2017: A 19-Month-Old Girl with Failure to Thrive.

Madhavan VL, Curran MA, Lindgren K.

N Engl J Med. 2018 Feb 15;378(7):686. doi: 10.1056/NEJMc1714806. No abstract available.

8.

Safety and tolerability of new-generation anti-obesity medications: a narrative review.

Patel DK, Stanford FC.

Postgrad Med. 2018 Mar;130(2):173-182. doi: 10.1080/00325481.2018.1435129. Epub 2018 Feb 8. Review.

PMID:
29388462
9.

Postbariatric Brachioplasty with Posteromedial Scar: Physical Model, Technical Refinements, and Clinical Outcomes.

Simone P, Carusi C, Segreto F, Iannuzzi R, Buscaglione S, Gizzi A, Giannitelli S, Rainer A, Filippi S, Persichetti P.

Plast Reconstr Surg. 2018 Feb;141(2):344-353. doi: 10.1097/PRS.0000000000004060.

PMID:
29369986
10.

Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.

Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, Borbély Y, Schultes B, Beglinger C, Drewe J, Schiesser M, Nett P, Bueter M.

JAMA. 2018 Jan 16;319(3):255-265. doi: 10.1001/jama.2017.20897.

11.

Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.

Salminen P, Helmiö M, Ovaska J, Juuti A, Leivonen M, Peromaa-Haavisto P, Hurme S, Soinio M, Nuutila P, Victorzon M.

JAMA. 2018 Jan 16;319(3):241-254. doi: 10.1001/jama.2017.20313.

12.

Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes.

Abbasi J.

JAMA. 2018 Jan 16;319(3):215-217. doi: 10.1001/jama.2017.20639. No abstract available.

PMID:
29340675
13.

Long-term Outcomes Following Bariatric Surgery.

Shubeck S, Dimick JB, Telem DA.

JAMA. 2018 Jan 16;319(3):302-303. doi: 10.1001/jama.2017.20521. No abstract available.

PMID:
29340664
14.

Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis.

Khera R, Pandey A, Chandar AK, Murad MH, Prokop LJ, Neeland IJ, Berry JD, Camilleri M, Singh S.

Gastroenterology. 2018 Apr;154(5):1309-1319.e7. doi: 10.1053/j.gastro.2017.12.024. Epub 2018 Jan 3. Review.

PMID:
29305933
15.

Gastric Bypass Surgery has Long-Term Health Benefits.

Rosenberg K.

Am J Nurs. 2018 Jan;118(1):56. doi: 10.1097/01.NAJ.0000529716.93343.6b. No abstract available.

PMID:
29280807
16.

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.

Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell M, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R.

Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1. Epub 2017 Dec 5.

PMID:
29221645
17.

Aldosterone Is Not Associated With Metabolic and Microvascular Insulin Sensitivity in Abdominally Obese Men.

Schütten MTJ, Kusters YHAM, Houben AJHM, Scheijen JLJM, van de Waarenburg MPH, Schalkwijk CG, Joris PJ, Plat J, Mensink RP, de Leeuw PW, Stehouwer CDA.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):759-767. doi: 10.1210/jc.2017-01541.

PMID:
29211893
18.

Claim More™: Empowering African American Women to Make Healthy Choices.

Tkatch R, Musich S, Draklellis J, Hetzel M, Banks J, Dugan J, Thompson K, Hawkins K.

J Holist Nurs. 2018 Mar;36(1):91-100. doi: 10.1177/0898010117691167. Epub 2017 Feb 12.

19.

Addressing Obesity in Aging Patients.

Batsis JA, Zagaria AB.

Med Clin North Am. 2018 Jan;102(1):65-85. doi: 10.1016/j.mcna.2017.08.007. Epub 2017 Oct 21. Review.

PMID:
29156188
20.

Obesity Pharmacotherapy.

Saunders KH, Umashanker D, Igel LI, Kumar RB, Aronne LJ.

Med Clin North Am. 2018 Jan;102(1):135-148. doi: 10.1016/j.mcna.2017.08.010. Review.

PMID:
29156182

Supplemental Content

Loading ...
Support Center